IBS & irritable bowel decisions — 2025

The Board granted the readjudication of service connection for diabetes, but denied or remanded other claims based on a lack of new and relevant evidence or due to incomplete medical records.

The appeal for service connection for irritable bowel syndrome was withdrawn by the Veteran and is therefore dismissed.

The Board remands the matter of entitlement to service connection for irritable bowel syndrome (IBS) as it requires additional evidence and an addendum opinion.

The Board denied an earlier effective date, a higher initial rating for scars with underlying soft tissue damage, and a compensable rating for stasis dermatitis. The IBS claim was remanded.

The Board denied various claims for earlier effective dates and service connection, dismissed a claim for an earlier effective date for Cushing's syndrome, and remanded claims for erectile dysfunction, multiple sclerosis, and TDIU.

The appeal was dismissed by the Veteran's request in a statement submitted on September 18, 2025.

The Board denied the Veteran's claim for an increased rating for gastroesophageal reflux disease (GERD) and did not find evidence to support a separate or increased rating for irritable bowel syndrome.

The Board remands the claims for increased disability evaluations for sinusitis, allergic rhinitis, irritable bowel syndrome, chronic cough of unknown etiology, and erectile dysfunction due to outstanding relevant VA treatment records.

The Veteran withdrew his appeal regarding the reduction in rating from 30 percent to noncompensable for irritable bowel syndrome (IBS).

The Board granted service connection for diabetes mellitus type II as secondary to the Veteran's service-connected disabilities and increased ratings of 10 percent were granted for irritable bowel syndrome (IBS) and tinea versicolor, while denying a compensable rating for allergic rhinitis and hemorrhoids.

The Board granted service connection for lumbosacral strain, right shoulder disability, left shoulder disability (secondary to right shoulder), obstructive sleep apnea (secondary to allergic rhinitis), irritable bowel syndrome (IBS), and posttraumatic stress disorder (PTSD).

The Board denied service connection for tinnitus, hypertension, traumatic brain injury (TBI), chronic joint pain, fibromyalgia, chronic fatigue syndrome (CFS), sleep apnea, and a gastrointestinal disability, claimed as gastrointestinal signs and symptoms (IBS).

The Board granted service connection for chronic headaches, CFS, IBS, bilateral restless leg syndrome, vertigo, GAD, persistent depressive disorder, and tinnitus. The appeal was denied for an increased rating in excess of 30 percent for chronic sinusitis and a compensable rating for allergic rhinitis.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support higher ratings or service connection for the claimed conditions.

The Board denied service connection for bilateral hearing loss, IBS, left hip disability, right hip disability, left knee disability, and right knee disability. The effective date of March 7, 2022, was granted for the award of service connection for right lower extremity sciatica, and November 18, 2021, was granted for GERD.

The appeal for compensation benefits related to insomnia disorder, irritable bowel syndrome, and hypertension has been withdrawn by the veteran.

The appeal for service connection for inguinal hernia, hypertension, left shoulder condition, and vision impairment was dismissed due to untimely filing of the notice of disagreement. The claims for headaches, OSA, IBS, and bilateral hearing loss were denied as there is no evidence linking these conditions to military service.

The Board granted earlier effective dates for some conditions and denied an earlier effective date for lumbosacral strain, while remanding service connection claims for left and right wrist disorders.

The Board granted an initial 10 percent rating for irritable bowel syndrome from August 10, 2022.

The Board granted an initial 30 percent disability rating for the service-connected irritable bowel syndrome (IBS) for the entire period on appeal.